Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5429
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hashweh, Nader Nael | en_US |
dc.contributor.author | Bartochowski, Zachary | en_US |
dc.contributor.author | Khoury, Rita | en_US |
dc.contributor.author | Grossberg, George T | en_US |
dc.date.accessioned | 2022-04-04T12:22:47Z | - |
dc.date.available | 2022-04-04T12:22:47Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 14656566 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/5429 | - |
dc.description.abstract | Alzheimer's disease (AD) is a major cause of morbidity worldwide and its prevalence is expected to rise. Previous studies involving compounds that target the accumulation of amyloid β protein have been unsuccessful, renewing interest in therapies directed against intracellular deposits of tau proteins. Derived from methylene blue, hydromethylthionine is a tau aggregation inhibitor that recently emerged as a promising disease-modifying treatment for AD. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Taylor & Francis Online | en_US |
dc.subject | Alzheimer’s disease | en_US |
dc.subject | Disease-modifying therapy | en_US |
dc.subject | Hydromethylthionine | en_US |
dc.subject | Leuco-methylthioninium | en_US |
dc.subject | Methylene blue | en_US |
dc.subject | Tau aggregation inhibitor | en_US |
dc.title | An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1080/14656566.2020.1719066 | - |
dc.identifier.pmid | 32037892 | - |
dc.identifier.scopus | 2-s2.0-85079467034 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85079467034 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 21 | en_US |
dc.description.issue | 6 | en_US |
dc.description.startpage | 617 | en_US |
dc.description.endpage | 627 | en_US |
dc.date.catalogued | 2022-04-04 | - |
dc.description.status | Published | en_US |
dc.identifier.ezproxyURL | http://ezsecureaccess.balamand.edu.lb/login?url=https://doi.org/10.1080/14656566.2020.1719066 | en_US |
dc.relation.ispartoftext | Expert Opinion on Pharmacotherapy | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
13
checked on Nov 16, 2024
Record view(s)
54
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.